Exosomes

Exosome therapy is a new biological regenerative treatment. We use the Organicell Flow product, an human amniotic fluid allograft which is recognized by the FDA as an investigational new drug (IND). Multi-center clinical trials are in progress for several indications, including SARS due to Covid 19 infection.  Organecell Flow is filtered and concentrated to increase the concentration of exosomes (cell secreted nano-particles) and micro-vesicles.  The exosomes  contain cytokines and growth factors which are involved in cellular differentiation and regeneration of tissues.  Age, chronic disease, environmental factors and genetic disorders can interfere with how our stem cells communicate with other cells, thus disrupting the healing process. Exosomes play a key role in the regulation of these communication processes. Organicell Flow is acellular, procured and processed according to the standards and regulations established by the FDA.  Donors are screened and qualified under FDA regulation, and receive standard serological screening for infectious disease.